CANTEX PHARMACEUTICALS INC. 13D and 13G filings for Chimerix, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-03 4:16 pm Sale | 2021-12-31 | 13G | Chimerix, Inc. CMRX | CANTEX PHARMACEUTICALS INC. | 3,500,000 4.000% | -6,500,000 (-65.00%) | Filing |